@ARTICLE{Ravanshad, author = {Attar Delgosha, Pedram and Ravanshad, Mehrdad and Maleki, Ali and }, title = {Evaluation of the Silymarin Effect on IL-10 and IL-17 Production in Chronic HCV Infected Patients}, volume = {15}, number = {1}, abstract ={Background and Aims: The use of herbal remedies, either in combination with conventional drugs or as an alternative, is accepted worldwide. Silymarin derived from Milk thistle has evidence-based therapeutic potency for wide spectrum of liver diseases. The current work aimed to study the immune-modulating activity of Silymarin in HCV-infected patients by measuring the effect of pure Silymarin solution on the production of IL-17 and IL-10. Materials and Methods: Nine HCV-1a infected patients and three healthy controls were entered in this study. The mean age of patients and healthy controls were 45.53 (± 10.21) and 39.9 (±10.88), respectively. The PBMCs were isolated, cultured in 96-well plate and incubated with Silymarin solution (5µg/ml) for 24 hours. The cells and cell culture supernatant of three groups including patients treated with Silymarin, non-treated patients, and healthy controls were then subjected to Real Time PCR and ELISA to measure the levels of inflammatory and non-inflammatory cytokines including IL-17 and IL-10, respectively. Statistical analysis was conducted using SPSS software version 20.0. Results: According to Real Time PCR and ELISA results, the level of IL-17 was significantly reduced in patients treated with Silymarin while the expression of IL-10 was remarkably increased in these patients. Conclusion: The results of this study approved the immunomodulatory properties of Silymarin in HCV-infected patients. Hepatoprotective, antiviral, as well as immune-modulatory properties of the Silymarin make it a potential therapeutic option in patients with chronic hepatitis C. }, URL = {http://journal.isv.org.ir/article-1-410-en.html}, eprint = {http://journal.isv.org.ir/article-1-410-en.pdf}, journal = {Iranian Journal of Virology}, doi = {}, year = {2021} }